Breaking News Instant updates and real-time market news.

CFMS

ConforMIS

$2.38

0.02 (0.85%)

17:11
01/04/18
01/04
17:11
01/04/18
17:11

ConforMIS: All patients treated with iTotal CR achieve alignment in target rnage

ConforMIS announced the publication of a prospective study in The Journal of Knee Surgery, a peer-reviewed orthopedic journal, on December 14, 2017. The study investigated the ability of the iTotal CR Knee Replacement System restoring coronal plane mechanical axis alignment in a patient's leg. The study, which was independently performed by Dr. Gary Levengood at Sports Medicine South in Lawrenceville, Georgia, examined 63 consecutive patients he operated on using the ConforMIS iTotal CR implant system and ConforMIS iJig patient-specific instrumentation. Results in each of the cases were verified using computer-assisted surgery. According to the study results, perfect neutral coronal mechanical alignment of 0 degrees was achieved in 84% of patients, with the remaining 16% of patients within +/-2 degrees of neutral. The patients had an average pre-operative deformity of 5.57 degrees , and a post-operative average of 0.18 degrees . Additionally, while 40 of the 63 patients had pre-operative extension deficits, no patients had postoperative extension deficits. According to the study, neutral mechanical limb alignment, or alignment within +/- 3 degrees , has previously been linked to better survivorship in TKA, while poor alignment has been linked to higher rates of implant failure. This study's findings are consistent with those of a previous published study by Ivie et.al. from the Journal of Arthroplasty in 2014, which concluded that the ConforMIS iTotal was 1.8 times more likely to achieve a neutral mechanical alignment as compared to standard off-the-shelf knees. "This independent study provides compelling new data demonstrating the accuracy of utilizing ConforMIS iJig instrumentation, with its built-in mechanical axis alignment and image guidance, in combination with our individually designed, patient-specific implants," said Mark Augusti, Chief Executive Officer and President of ConforMIS. "Importantly, it is consistent with earlier published results. One of the drawbacks of patient-specific cutting guides when used with standard off-the-shelf implants that are not patient-specific has been the inability to consistently achieve neutral mechanical alignment. Dr. Levengood's data demonstrate that the ConforMIS iTotal CR system does not share this problem. This study adds enlightening data and analysis to the growing body of evidence that ConforMIS iJig Instrumentation, when used in conjunction with ConforMIS individually designed, patient-specific iTotal implants, provides superior results compared to other patient-specific instrumentation used with off-the-shelf implants."

  • 26

    Feb

CFMS ConforMIS
$2.38

0.02 (0.85%)

08/04/17
DBAB
08/04/17
DOWNGRADE
Target $5
DBAB
Hold
ConforMIS downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Brittany Henderson downgraded ConforMIS to Hold and trimmed its price target to $5 from $6 following the Q2 miss and reduced full year outlook and said changes in the company's commercial strategy could take longer to play out than previously expected.
12/20/17
BTIG
12/20/17
UPGRADE
BTIG
Buy
ConforMIS upgraded to Buy from Neutral at BTIG
12/20/17
12/20/17
UPGRADE
Target $4

Buy
ConforMIS upgraded to Buy at BTIG
As previously reported, BTIG analyst Ryan Zimmerman upgraded ConforMIS to Buy from Neutral, with a $4 price target, saying that while it still needs to improve production times, increase margins, and grow faster, at this valuation the risk/reward is favorable. Further, the analyst believes the strategies management has undertaken over the previous year could begin to bear fruit in FY18 and any return to growth will begin to lift shares.
01/02/18
JPMS
01/02/18
DOWNGRADE
JPMS
Underweight
ConforMIS downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Michael Weinstein downgraded ConforMIS to Underweight without a price target. The analyst finds it "tough" to recommend owning the stock in 2018 given the company's cash burn, limited sales growth and the potential for additional financing at some point in the next 12 months.

TODAY'S FREE FLY STORIES

05:50
04/25/18
04/25
05:50
04/25/18
05:50
General news
FX Action: USD-JPY corrected to a 108.98 low »

FX Action: USD-JPY…

CHKP

Check Point

$102.95

0.17 (0.17%)

05:38
04/25/18
04/25
05:38
04/25/18
05:38
Earnings
Check Point reports Q1 EPS $1.30, consensus $1.28 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

DISCA

Discovery

$23.94

0.17 (0.72%)

05:36
04/25/18
04/25
05:36
04/25/18
05:36
Hot Stocks
Discovery enters partnership with Digital Element »

Digital Element announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

SOGO

Sogou

$8.55

0.15 (1.79%)

05:35
04/25/18
04/25
05:35
04/25/18
05:35
Earnings
Breaking Earnings news story on Sogou »

Sogou sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

SOGO

Sogou

$8.55

0.15 (1.79%)

05:34
04/25/18
04/25
05:34
04/25/18
05:34
Earnings
Sogou reports Q1 EPS 5c, consensus 3c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

CYOU

Changyou.com

$28.79

-0.9 (-3.03%)

05:32
04/25/18
04/25
05:32
04/25/18
05:32
Earnings
Changyou.com sees Q2 EPS 38c-47c, consensus 53c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

CYOU

Changyou.com

$28.79

-0.9 (-3.03%)

05:30
04/25/18
04/25
05:30
04/25/18
05:30
Earnings
Changyou.com reports Q1 adj. EPS (30c), may not compare to consensus 53c »

Reports Q1 revenue $137M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

SOHU

Sohu.com

$30.26

-0.65 (-2.10%)

05:29
04/25/18
04/25
05:29
04/25/18
05:29
Earnings
Sohu.com sees Q2 EPS ($1.65)-($1.40), consensus ($1.32) »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

SOHU

Sohu.com

$30.26

-0.65 (-2.10%)

05:28
04/25/18
04/25
05:28
04/25/18
05:28
Earnings
Breaking Earnings news story on Sohu.com »

Sohu.com reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

SOHU

Sohu.com

$30.26

-0.65 (-2.10%)

05:26
04/25/18
04/25
05:26
04/25/18
05:26
Earnings
Sohu.com reports Q1 EPS ($2.39), consensus ($1.56) »

Reports Q1 revenue $455M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

FOSL

Fossil

$14.21

-0.165 (-1.15%)

05:25
04/25/18
04/25
05:25
04/25/18
05:25
Hot Stocks
Fossil signs global license partnership with PUMA for watches, smartwatches »

Fossil Group and PUMA SE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$77.00

-0.595 (-0.77%)

05:23
04/25/18
04/25
05:23
04/25/18
05:23
Hot Stocks
Novartis announces launch of FocalView app »

Novartis announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    May

  • 21

    May

  • 05

    Jun

EEFT

Euronet

$75.32

-1.04 (-1.36%)

05:22
04/25/18
04/25
05:22
04/25/18
05:22
Earnings
Breaking Earnings news story on Euronet »

Euronet sees Q2 adj. EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

EEFT

Euronet

$75.32

-1.04 (-1.36%)

05:21
04/25/18
04/25
05:21
04/25/18
05:21
Earnings
Euronet reports Q1 adj. EPS 73c, consensus 73c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

ILMN

Illumina

$238.65

-7.19 (-2.92%)

05:02
04/25/18
04/25
05:02
04/25/18
05:02
Recommendations
Illumina analyst commentary  »

Illumina target upped to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 24

    May

  • 12

    Jun

PPG

PPG

$105.74

-3.12 (-2.87%)

04:56
04/25/18
04/25
04:56
04/25/18
04:56
Upgrade
PPG rating change  »

PPG upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACN

Accenture

$151.02

-2.07 (-1.35%)

04:55
04/25/18
04/25
04:55
04/25/18
04:55
Conference/Events
Accenture to host analyst and investor meeting »

Analyst and Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

AKAM

Akamai

$70.95

-0.73 (-1.02%)

, MRK

Merck

$60.08

-0.16 (-0.27%)

04:55
04/25/18
04/25
04:55
04/25/18
04:55
Conference/Events
Boardroom Resources to hold a summit »

2018 Boardroom Summit…

AKAM

Akamai

$70.95

-0.73 (-1.02%)

MRK

Merck

$60.08

-0.16 (-0.27%)

JNJ

Johnson & Johnson

$126.18

-0.65 (-0.51%)

LPLA

LPL Financial

$61.04

-0.5 (-0.81%)

GHC

Global Consumer Acquisition Corporation

$611.35

-4.65 (-0.75%)

FUN

Cedar Fair

$63.63

-0.44 (-0.69%)

DECK

Deckers Brands

$90.83

1.13 (1.26%)

CPB

Campbell Soup

$41.08

0.25 (0.61%)

BURBY

Burberry

AWK

American Water

$84.79

0.5 (0.59%)

BLK

BlackRock

$514.01

-5.79 (-1.11%)

STT

State Street

$101.07

-1.28 (-1.25%)

EA

Electronic Arts

$118.56

-0.99 (-0.83%)

HSY

Hershey

$92.81

-0.33 (-0.35%)

EQR

Equity Residential

$60.62

0.21 (0.35%)

APOG

Apogee Enterprises

$41.55

-1.11 (-2.60%)

VMC

Vulcan Materials

$111.32

-2.53 (-2.22%)

WEN

Wendy's

$16.84

-0.385 (-2.24%)

TWX

Time Warner

$96.02

-0.32 (-0.33%)

AMGN

Amgen

$171.91

-2.75 (-1.57%)

AGN

Allergan

$156.91

-2.98 (-1.86%)

CSCO

Cisco

$43.74

-0.49 (-1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 26

    Apr

  • 26

    Apr

  • 27

    Apr

  • 27

    Apr

  • 28

    Apr

  • 30

    Apr

  • 30

    Apr

  • 30

    Apr

  • 01

    May

  • 02

    May

  • 02

    May

  • 03

    May

  • 03

    May

  • 08

    May

  • 08

    May

  • 08

    May

  • 08

    May

  • 09

    May

  • 15

    May

  • 17

    May

  • 21

    May

  • 22

    May

  • 23

    May

  • 23

    May

  • 28

    May

  • 30

    May

  • 05

    Jun

  • 05

    Jun

  • 07

    Jun

  • 12

    Jun

  • 14

    Jun

  • 23

    Oct

ANF

Abercrombie & Fitch

$27.03

0.265 (0.99%)

04:55
04/25/18
04/25
04:55
04/25/18
04:55
Conference/Events
Abercrombie & Fitch to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 12

    Jun

NVS

Novartis

$77.00

-0.595 (-0.77%)

, GSK

GlaxoSmithKline

$40.63

0.29 (0.72%)

04:55
04/25/18
04/25
04:55
04/25/18
04:55
Conference/Events
Drug Information Association to hold a forum »

Biostatistics Industry…

NVS

Novartis

$77.00

-0.595 (-0.77%)

GSK

GlaxoSmithKline

$40.63

0.29 (0.72%)

LLY

Eli Lilly

$80.09

-0.16 (-0.20%)

AZN

AstraZeneca

$35.13

-0.4 (-1.13%)

MRK

Merck

$60.08

-0.16 (-0.27%)

AMGN

Amgen

$171.91

-2.75 (-1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 27

    Apr

  • 30

    Apr

  • 01

    May

  • 07

    May

  • 08

    May

  • 15

    May

  • 17

    May

  • 18

    May

  • 21

    May

  • 22

    May

  • 28

    May

  • 05

    Jun

  • 07

    Jun

  • 07

    Jun

  • 23

    Oct

04:55
04/25/18
04/25
04:55
04/25/18
04:55
Conference/Events
UBS basic materials analyst to hold an analyst/industry conference call »

Basic Materials Analyst…

SBPH

Spring Bank Pharmaceuticals

$14.50

0.18 (1.26%)

04:55
04/25/18
04/25
04:55
04/25/18
04:55
Conference/Events
Spring Bank Pharmaceuticals management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 25

    May

IOVA

Iovance Biotherapeutics

$14.40

-0.1 (-0.69%)

04:55
04/25/18
04/25
04:55
04/25/18
04:55
Conference/Events
Iovance Biotherapeutics management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 21

    May

04:55
04/25/18
04/25
04:55
04/25/18
04:55
General news
Breaking General news story  »

Week of 4/20 MBA Mortgage…

CHPE

Chaparral Energy

04:55
04/25/18
04/25
04:55
04/25/18
04:55
Conference/Events
Chaparral Energy management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.